share_log

HC Wainwright & Co. Reiterates Buy on OKYO Pharma, Maintains $7 Price Target

Benzinga ·  Jul 11, 2024 18:09

HC Wainwright & Co. analyst Yi Chen reiterates OKYO Pharma (NASDAQ:OKYO) with a Buy and maintains $7 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment